(Q42646666)

4 November 2017

0 references

The hepatitis C epidemic, shall we remain silent? (English)

1 reference

4 November 2017

Paredes A

1

1 reference

4 November 2017

Zweben JE

series ordinal

2

1 reference

4 November 2017

language of work or name

1 reference

1 January 2001

1 reference

Journal of Addictive Diseases

4 November 2017

published in

1 reference

4 November 2017

volume

20

1 reference

4 November 2017

issue

1

1 reference

4 November 2017

page(s)

1-7

1 reference

Pretreatment evaluation of chronic hepatitis C: risks, benefits, and costs

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_01

Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_01

Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_01

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_01

Roles of alcohol, hepatitis virus infection, and gender in the development of hepatocellular carcinoma in patients with liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_01

Progression of type C chronic hepatitis to liver cirrhosis and hepatocellular carcinoma--its relationship to alcohol drinking and the age of transfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_01

21 January 2018

Hepatitis C and alcohol

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_01

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_01

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_01

Seroprevalence of hepatitis A, B, C, and D markers and liver function abnormalities in intravenous heroin addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_01

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_01

The treatment of chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_01

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_01

Hepatitis C in methadone maintenance patients: prevalence and public policy implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_01

Hepatitis C: education and counseling issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_01

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 3-1999. A 41-year-old woman with muscle weakness, painful paresthesias, and visual problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_01

Hepatitis C, B, D, and A: contrasting features and liver function abnormalities in heroin addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_01

Fulminant Hepatitis Associated with Hepatitis A Virus Superinfection in Patients with Chronic Hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N01_01

21 January 2018

Identifiers

DOI

10.1300/J069V20N01_01

1 reference

4 November 2017

1 reference